Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy

C. S. Ulrik, Z. Diamant (Copenhagen, Denmark; Leiden, Netherlands)

Source: Annual Congress 2006 - New developments in the treatment and management of asthma
Session: New developments in the treatment and management of asthma
Session type: Oral Presentation
Number: 779
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. S. Ulrik, Z. Diamant (Copenhagen, Denmark; Leiden, Netherlands). Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy. Eur Respir J 2006; 28: Suppl. 50, 779

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

Effects of regular formoterol treatment on airway hyperresponsiveness in patients with mild to moderate asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 285s
Year: 2003

Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial
Source: Eur Respir J 2007; 30: 457-466
Year: 2007



Effects of corticosteroids on airway inflammation in cough variant asthma
Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring
Year: 2004

Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Source: Eur Respir J 2002; 20: 1080-1087
Year: 2002



Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006

Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and mild bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002

Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Same role and same treatment for airway eosinophilia in asthma and COPD?
Source: Eur Respir J 2007; 29: 831-833
Year: 2007


Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma
Source: Eur Respir J 2001; 17: 374-379
Year: 2001



Dissociation in effects of fluticasone but not fluticasone/salmeterol on lung function and airway hyperresponsiveness in mild persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 385s
Year: 2002

Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Effects of add-on omalizumab therapy on airway wall thickening in severe persistent asthma
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011


Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Influence of controller therapy with extrafine beclometasone/formoterol on the quality of life of asthma patients with cold and/or osmotic airway hyperresponsiveness
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019


The effect of salmeterol/fluticasone on markers of airway inflammation in patients with uncontrolled asthma
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012